Jessica Dallas

Cooley advised Apollo Endosurgery, a medical device company, on its agreement to be acquired by Boston Scientific in an all-cash transaction with an enterprise value of approximately $615 million.

Cooley advised AiFi on its $65 million Series B funding round. Partner Gordon Ho led the Cooley team advising AiFi, which is a flexible artificial intelligence platform that enables retailers to affordably deploy and scale autonomous shopping solutions.

Cooley advised publicly traded clinical-stage immuno-oncology company Forty Seven on its agreement to sell to Gilead for $4.9 billion in all cash. Partners Jamie Leigh, Ben Beerle, Eric Jensen and John McKenna led the Cooley team advising Forty Seven on the transaction, which is expected close in Q2.

Cooley advised 1Life Healthcare, Inc. on its $281.8 million initial public offering of 20,125,000 shares of common stock, including full exercise of the underwriters’ option to purchase additional shares. 1Life Healthcare whose securities now trade on the Nasdaq Global Select Market under the symbol “ONEM,” is a membership-based primary care platform with seamless digital health and inviting in-office care, convenient to where people work, shop, live and click. Partners Matthew Hemington and John McKenna led the Cooley team.